Insider Cluster (2 insiders) ·Filed Jul 3, 2026

IMNM

Immunome Inc.
BEARISH
Impact 5/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $2.9M total
Actionable Insight ▼ Bearish

Insider selling is consistent across multiple insiders but modest relative to market cap — the selling is likely not a material signal of deterioration. However, the persistent lack of insider buying and the company's poor historical stock response to prior reports (avg T+20 alpha -6%) suggest continued weakness. Monitor for any negative pipeline updates or upcoming financing events.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
IMNM ▼ -8.17% at T+60d
SHORT call ✓ call won +8.17% · α vs SPY +11.74% · entry $23.61 → $21.68
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
+1.23%
call -1.23% · α -0.36%
$23.90
settled 3mo ago
T+5d
+2.37%
call -2.37% · α -1.44%
$24.17
settled 3mo ago
T+20d
-2.24%
call +2.24% · α +1.83%
$23.08
settled 2mo ago
T+60d
-8.17%
call +8.17% · α +11.74%
$21.68
settled 4d ago

Price Chart

Loading chart...

Executive Summary

Director Isaac Barchas and CMO Robert Lechleider sold a combined $2.93M in open-market sales over a week, with Barchas alone accounting for $2.13M. The cluster is entirely selling, and the total value (~0.12% of $2.4B market cap) is modest. Historical insider activity shows $6.6M in selling over 30 days, continuing this pattern.

Key Financial Metrics

Direction
selling
Total Value
$2.9M
Insiders
2

Key Facts

  • Director Barchas sold 76k shares at $22.35 on 7/2, 24k at $23.33 on 7/2, and 101k at $21.12 on 6/30; total Barchas sales = $4.39M across the cluster window
  • CMO Lechleider sold 41k shares at $19.56 for $794k
  • Cluster total: $2.93M in open-market sales; prior-30d insider selling totaled $6.6M
  • No insider buying in the cluster — net direction is selling
  • Market cap is $2.4B; cluster value is ~0.12% of market cap, below the 0.5% materiality threshold for outsized significance

Financial Impact

Total insider sales of $2.93M in this cluster (~0.12% of market cap), with $4.39M from the director alone.

insider sellingownershipshare supply

Risk Factors

  • Continued insider selling without buying could signal unstated concerns
  • Biotech sector: any pipeline setback would compound selling pressure
  • Historical stock drift has been negative after most filings; the pattern is bearish

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMNM-1783038756017
13 reports for IMNM
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +26.53%May 28, 2026
Filters
Rows
Reports for IMNM — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$21.58 awaiting T+5awaiting T+5—$20.97 (−2.85%)
Sep 21, 2026
11d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$25.07 $21.68▼ −13.52%▼ −13.24%$20.97 (−16.37%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$26.42 $28.08▲ +6.28%▲ +8.25%$20.97 (−20.65%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.25 $27.56▲ +4.99%▲ +5.39%$20.97 (−20.13%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.35 $22.20▼ −4.93%▼ −4.36%$20.97 (−10.21%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 3, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$23.61 $24.17▼ −2.37%▼ −1.44%$20.97 (+11.20%)
May 28, 2026
18w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$22.54 $19.81▼ −12.11%▼ −12.06%$20.97 (−6.99%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$22.20 $19.66▼ −11.44%▼ −10.28%$20.97 (−5.56%)
Showing 10 of 13

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026